Clearview Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Clearview Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12	Closed	-$307	–	154
2023 Q2	$307	Hold	12	–	–	﹤0.01%	648
2023 Q1	$357	Hold	12	–	–	﹤0.01%	630
2022 Q4	$325	Hold	12	–	–	﹤0.01%	578
2022 Q3	$0	Sell	12 -13	-52%	-$340	﹤0.01%	576
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	520
2022 Q1	$1K	Sell	25 -3	-11%	-$97	﹤0.01%	549
2021 Q4	$1K	Hold	28	–	–	﹤0.01%	611
2021 Q3	$1K	Sell	28 -13	-32%	-$441	﹤0.01%	605
2021 Q2	$1K	Hold	41	–	–	﹤0.01%	602
2021 Q1	$2K	Hold	41	–	–	﹤0.01%	539
2020 Q4	$2K	Buy	+41	New	+$1.71K	﹤0.01%	501

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearview Wealth Advisors's AVNS Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 12 shares — an estimated $307 sold.

Clearview Wealth Advisors first reported a position in AVNS in Q4 2020 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

Clearview Wealth Advisors reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
Clearview Wealth Advisors sold 12 Avanos Medical shares in Q3 2023, an estimated $307.
Clearview Wealth Advisors first reported a position in Avanos Medical in Q4 2020 and held it in 11 quarters.
Clearview Wealth Advisors's Avanos Medical position peaked at $2K in Q1 2021.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.